The J&J vaccine is back. Next comes trust.

The J&J vaccine is back. Next comes trust.
Last week US regulators recommended resuming use of the Johnson & Johnson vaccine, after deciding that a side effect involving blood clots was too rare to justify continuing the brief suspension they had imposed: there were just 15 reported instances out of 8 million doses. But even though the pause lasted just 11 days, it…
Read More

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.